Drug Pipeline

Collagenase Clostridium Histolyticum (CCH) 2.9 MG/ML [Xiaflex] Clinical Trials

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
3
Active Studies
1
Recruiting
3
Top Sponsors
2
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-06-05 NCT05777031
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP…		 overall status: "Recruiting" → "Active Not Recruiting"
2026-06-05 NCT05777031
Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP…		 Enrollment reduced: 22 -> 12 participants
Active Studies by Phase
Phase 4
2
Not specified
1
Active Trials
NCT IDTitleConditionStatus
Phase 4
NCT03192020 Trial Comparing Treatment Strategies in Dupuytren's Contracture Dupuytren Contracture Active, Not Recruiting
NCT05777031 Safety and Efficacy of Collagenase Clostridium Histolyticum After Prior Intralesional PRP… Peyronie Disease Active, Not Recruiting
Not specified
NCT06065436 Concurrent Low Intensity Shockwave Therapy on Collagenase Clostridium Histolyticum for… Peyronie Disease Recruiting
Sponsors Running Collagenase Clostridium Histolyticum (CCH) 2.9 MG/ML [Xiaflex] Trials
Tampere University (1) University of Miami (1) Mayo Clinic (1)
Get alerts when Collagenase Clostridium Histolyticum (CCH) 2.9 MG/ML [Xiaflex] trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free